GlassScriptPhysician profile
Olivia S Locker
NPI 1336218304
$2,987.69
in general payments reported to CMS, 2019-2025
17 companies · $627 in 2025
The $627 reported for 2025 was more than what 78% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71.33 · 2020: $59.49 · 2021: $252 · 2022: $510 · 2023: $1,033 · 2024: $435 · 2025: $627.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,896 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,895.57 |
| Education | $199.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $917.61 | 2022-2025 | Austedo Xr, Austedo Xr, Austedo |
| Abbvie INC. | $530.69 | 2021-2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $488.88 | 2021-2025 | Caplyta |
| Neurocrine Biosciences, INC. | $268.56 | 2019-2025 | Ingrezza |
| Alkermes, INC. | $201.29 | 2022-2025 | Aristada, Lybalvi |
| Corium, LLC | $130.50 | 2022-2024 | Azstarys |
| Ironshore Pharmaceuticals INC. | $89.82 | 2023-2024 | Jornay Pm |
| Allergan, INC. | $64.22 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $60.66 | 2024-2025 | Cobenfy |
| Axsome Therapeutics, INC. | $51.78 | 2023-2024 | Auvelity |
| Collegium Pharmaceutical, INC. | $41.31 | 2025 | Jornay Pm |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $36.68 | 2019-2020 | |
| Lundbeck LLC | $29.76 | 2022 | |
| Adlon Therapeutics L.P. | $24.81 | 2021 | |
| Shire North American Group INC | $18.27 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $16.82 | 2024 | Rexulti |
| Sage Therapeutics, LLC | $16.03 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olivia Locker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.